Biotech

All articles by Biotech

Diabetes space continues to run hot with Vertex/ViaCyte deal
Diabetes space continues to run hot with Vertex/ViaCyte deal
Jack O'Brien
July 11, 2022
3:31 pm

Vertex’s $320 million cash acquisition of ViaCyte is anticipated to close by the end of the year.

Bluebird’s adcomm sweep sets stage for gene-therapy launches
Bluebird’s adcomm sweep sets stage for gene-therapy launches
Marc Iskowitz
June 13, 2022
2:39 pm

Bluebird’s wins were followed by news over the weekend that patients with inherited blood disease saw prolonged benefit from gene-edited therapy.

BlueBird Bio’s 2-day reckoning is at hand
BlueBird Bio’s 2-day reckoning is at hand
Marc Iskowitz
June 9, 2022
9:36 am

Briefing documents suggest that one of two potential gene therapy launches may be in for a rough ride.

LGBTQIA+ leaders in biotech discuss representation, external challenges facing community
LGBTQIA+ leaders in biotech discuss representation, external challenges facing community
Jack O'Brien
June 8, 2022
2:47 pm

The recent wave of anti-LGBTQIA+ legislation has biotech leaders stepping up and speaking out.

Q&A: OUTBio’s president on the meaning of Pride Month
Q&A: OUTBio’s president on the meaning of Pride Month
Jack O'Brien
June 3, 2022
1:12 pm

Ramsey Johnson, president and founder of OUTBio, discusses the importance of LGBTQIA+ representation in the biotech sector.

Ahead of ASCO meet, two oncology upstarts run into difficulty
Ahead of ASCO meet, two oncology upstarts run into difficulty
Marc Iskowitz
June 1, 2022
9:18 am

Even amid a disappointing year for the biotech sector, setbacks facing the two biotechs stand out.

Is Samsung really ‘at negotiating table’ for Biogen? What we know so far
Is Samsung really ‘at negotiating table’ for Biogen? What we know so far
Marc Iskowitz
December 30, 2021
3:01 pm

Samsung, said to be negotiating a $42 billion takeover of Biogen, has denied a Korean media outlet’s report about the deal.

Monte Rosa Therapeutics promotes Jullian Jones to chief business officer
Monte Rosa Therapeutics promotes Jullian Jones to chief business officer
Lecia Bushak
December 3, 2021
2:00 pm

She previously served as SVP, head of business development.

Carisma Therapeutics appoints CFO
Carisma Therapeutics appoints CFO
Larry Dobrow
June 10, 2021
1:00 pm

Biotech veteran Richard Morris joins the company from Passage Bio.

Five things for health marketers to know: Thursday, June 3, 2021
Five things for health marketers to know: Thursday, June 3, 2021
Lecia Bushak
June 3, 2021
5:00 am

Biden administration launches community-based incentives to boost vaccinations; MorphoSys acquires Constellation Pharmaceuticals; Novartis releases promising Cosentyx results.

  • From Our Partners